306 related articles for article (PubMed ID: 23179369)
21. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
22. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
Kim BS; Oh ST; Yook JH; Kim BS
Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
[TBL] [Abstract][Full Text] [Related]
23. Should we remove splenic hilus lymph nodes for esophagogastric junction adenocarcinoma?
Hartgrink HH
Gastric Cancer; 2013 Oct; 16(4):454-6. PubMed ID: 23417699
[No Abstract] [Full Text] [Related]
24. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
[TBL] [Abstract][Full Text] [Related]
26. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
[No Abstract] [Full Text] [Related]
27. Laparoscopic en bloc lower mediastinal lymph node dissection via transhiatal approach for adenocarcinoma of esophagogastric junction.
Sakaguchi M; Hosogi H; Kanaya S
Surg Oncol; 2021 Mar; 36():34-35. PubMed ID: 33285434
[TBL] [Abstract][Full Text] [Related]
28. Recurrence Pattern and Lymph Node Metastasis of Adenocarcinoma at the Esophagogastric Junction.
Suh YS; Lee KG; Oh SY; Kong SH; Lee HJ; Kim WH; Yang HK
Ann Surg Oncol; 2017 Nov; 24(12):3631-3639. PubMed ID: 28828728
[TBL] [Abstract][Full Text] [Related]
29. [Effect of splenic hilar lymphadenectomy on locally advanced Siewert type Ⅱ and Ⅲ adenocarcinoma of esophagogastric junction with a tumor diameter ≥4 cm: a five-year survival analysis].
Lin JX; Wu D; Jiang YM; Chen JY; Lin GT; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Zheng CH; Huang CM
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):853-859. PubMed ID: 36058712
[No Abstract] [Full Text] [Related]
30. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
[TBL] [Abstract][Full Text] [Related]
31. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases.
Duan X; Shang X; Tang P; Jiang H; Yu Z
ANZ J Surg; 2018 Apr; 88(4):E264-E267. PubMed ID: 28503799
[TBL] [Abstract][Full Text] [Related]
32. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
Goto H; Tokunaga M; Miki Y; Makuuchi R; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
Gastric Cancer; 2014 Mar; 18(2):375-81. PubMed ID: 24658651
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features of submucosal carcinoma of the stomach.
Hanazaki K; Wakabayashi M; Sodeyama H; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
J Clin Gastroenterol; 1997 Apr; 24(3):150-5. PubMed ID: 9179733
[TBL] [Abstract][Full Text] [Related]
34. Optimal surgical management for esophagogastric junction carcinoma.
Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
[TBL] [Abstract][Full Text] [Related]
36. Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.
Cai MZ; Lv CB; Cai LS; Chen QX
Medicine (Baltimore); 2019 Dec; 98(51):e18451. PubMed ID: 31861019
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
[TBL] [Abstract][Full Text] [Related]
38. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
[TBL] [Abstract][Full Text] [Related]
39. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
40. Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.
Yin Q; Wang W; Liu H; Yang G; Zhou S; Liu L
J Cardiothorac Surg; 2019 Nov; 14(1):207. PubMed ID: 31775820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
